Embolic Material Migration as the Predominant Contributing Factor to Prognostic Deterioration Following Combined Tumor Resection and Preoperative Embolization

Introduction Preoperative embolization can potentially facilitate surgical resection of challenging tumors in the intracranial and facial regions; however, its clinical efficacy remains controversial, mainly due to potential morbidity risks. We explored negative factors of the combined treatment of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2024-03, Vol.16 (3), p.e57315-e57315
Hauptverfasser: Suzuki, Ryosuke, Akimoto, Taisuke, Miyake, Shigeta, Iida, Yu, Shimohigoshi, Wataru, Nakai, Yasunobu, Shimizu, Nobuyuki, Sakata, Katsumi, Yamamoto, Tetsuya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e57315
container_issue 3
container_start_page e57315
container_title Curēus (Palo Alto, CA)
container_volume 16
creator Suzuki, Ryosuke
Akimoto, Taisuke
Miyake, Shigeta
Iida, Yu
Shimohigoshi, Wataru
Nakai, Yasunobu
Shimizu, Nobuyuki
Sakata, Katsumi
Yamamoto, Tetsuya
description Introduction Preoperative embolization can potentially facilitate surgical resection of challenging tumors in the intracranial and facial regions; however, its clinical efficacy remains controversial, mainly due to potential morbidity risks. We explored negative factors of the combined treatment of preoperative embolization and tumor resection that affect neurological prognosis. Method This retrospective study used clinical data from 132 consecutive tumors that underwent combined treatment at multiple facilities between January 2016 and May 2021. Basic patient information, tumor characteristics, and treatment details were assessed to identify predictors of deterioration as measured using the modified Rankin scale (mRS) score at three months post-treatment. Results Among the 126 eligible combined treatments, a deterioration in the postoperative mRS score was observed in 19/126 (15.1%). Complications related to embolization and tumor resection occurred in 8/126 (6.3%) and 19/125 (15.2%) of procedures, respectively. Multivariate analyses indicated significant associations between migration of embolic material (adjusted odds ratio 13.80; 95% confidence interval 1.25-152.52; p=0.03), elevated intraoperative blood loss (p=0.04), and deterioration of postoperative mRS score. Embolic material migration was identified as the primary prognostic factor for the deterioration of score. An analysis of 192 procedures, excluding those that exclusively used coils, identified embolization targeting the accessory meningeal artery (p=0.046) and the third segment of the internal maxillary artery (p=0.03) as a risk factor for embolic material migration. Conclusions Embolic material migration is the predominant factor associated with declining neurological outcome that persists into the chronic phase after combined treatment. Given that preoperative embolization is a supplementary treatment option, a thorough understanding of vascular anatomy and striving safe procedure are critical.
doi_str_mv 10.7759/cureus.57315
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11060013</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3049816527</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-a5e5e6f3a54acb64f45ab7c1ae9e9f8d4d73537f2a6c91138c36d0c3df5ba263</originalsourceid><addsrcrecordid>eNpdkcFu1DAQhi0EolXpjTOyxIUDW-w4jpMTQksXkFqB0N4tx5lsXSWexXZawcPwrDibpSqcbMnffDPjn5CXnF0oJZt3dgowxQupBJdPyGnBq3pV87p8-uh-Qs5jvGWMcaYKpthzciLqqmGlKk_J78uxxcFZem0SBGcGeu12wSSHnppI0w3QbwE6HJ03PtE1-hRcOyXnd3RjbMJAE2YEdx5jyp6PMHvwqNjgMOD9DK9xbJ2Hjm6nMRd9hwh26eK7uQXuYa65A7pM9OsgeEGe9WaIcH48z8h2c7ldf15dff30Zf3hamUFY2llJEioemFkaWxblX0pTassN9BA09dd2SkhheoLU9mGc1FbUXXMiq6XrSkqcUbeL9r91I7QWchbmkHvgxtN-KnROP3vi3c3eod3mnNW5Y8V2fDmaAj4Y4KY9OiihWEwHnCKWrCyUbySUmb09X_oLU7B5_UOVJ2pQmXq7ULZgDEG6B-m4UzP2esle33IPuOvHm_wAP9NWvwBoUKwrA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3049816527</pqid></control><display><type>article</type><title>Embolic Material Migration as the Predominant Contributing Factor to Prognostic Deterioration Following Combined Tumor Resection and Preoperative Embolization</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Suzuki, Ryosuke ; Akimoto, Taisuke ; Miyake, Shigeta ; Iida, Yu ; Shimohigoshi, Wataru ; Nakai, Yasunobu ; Shimizu, Nobuyuki ; Sakata, Katsumi ; Yamamoto, Tetsuya</creator><creatorcontrib>Suzuki, Ryosuke ; Akimoto, Taisuke ; Miyake, Shigeta ; Iida, Yu ; Shimohigoshi, Wataru ; Nakai, Yasunobu ; Shimizu, Nobuyuki ; Sakata, Katsumi ; Yamamoto, Tetsuya</creatorcontrib><description>Introduction Preoperative embolization can potentially facilitate surgical resection of challenging tumors in the intracranial and facial regions; however, its clinical efficacy remains controversial, mainly due to potential morbidity risks. We explored negative factors of the combined treatment of preoperative embolization and tumor resection that affect neurological prognosis. Method This retrospective study used clinical data from 132 consecutive tumors that underwent combined treatment at multiple facilities between January 2016 and May 2021. Basic patient information, tumor characteristics, and treatment details were assessed to identify predictors of deterioration as measured using the modified Rankin scale (mRS) score at three months post-treatment. Results Among the 126 eligible combined treatments, a deterioration in the postoperative mRS score was observed in 19/126 (15.1%). Complications related to embolization and tumor resection occurred in 8/126 (6.3%) and 19/125 (15.2%) of procedures, respectively. Multivariate analyses indicated significant associations between migration of embolic material (adjusted odds ratio 13.80; 95% confidence interval 1.25-152.52; p=0.03), elevated intraoperative blood loss (p=0.04), and deterioration of postoperative mRS score. Embolic material migration was identified as the primary prognostic factor for the deterioration of score. An analysis of 192 procedures, excluding those that exclusively used coils, identified embolization targeting the accessory meningeal artery (p=0.046) and the third segment of the internal maxillary artery (p=0.03) as a risk factor for embolic material migration. Conclusions Embolic material migration is the predominant factor associated with declining neurological outcome that persists into the chronic phase after combined treatment. Given that preoperative embolization is a supplementary treatment option, a thorough understanding of vascular anatomy and striving safe procedure are critical.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.57315</identifier><identifier>PMID: 38690474</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Asymptomatic ; Clinical outcomes ; Embolization ; Hemorrhage ; Lymphoma ; Medical prognosis ; Migration ; Neurological disorders ; Neurosurgery ; Thromboembolism ; Tumors</subject><ispartof>Curēus (Palo Alto, CA), 2024-03, Vol.16 (3), p.e57315-e57315</ispartof><rights>Copyright © 2024, Suzuki et al.</rights><rights>Copyright © 2024, Suzuki et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2024, Suzuki et al. 2024 Suzuki et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c300t-a5e5e6f3a54acb64f45ab7c1ae9e9f8d4d73537f2a6c91138c36d0c3df5ba263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11060013/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11060013/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38690474$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suzuki, Ryosuke</creatorcontrib><creatorcontrib>Akimoto, Taisuke</creatorcontrib><creatorcontrib>Miyake, Shigeta</creatorcontrib><creatorcontrib>Iida, Yu</creatorcontrib><creatorcontrib>Shimohigoshi, Wataru</creatorcontrib><creatorcontrib>Nakai, Yasunobu</creatorcontrib><creatorcontrib>Shimizu, Nobuyuki</creatorcontrib><creatorcontrib>Sakata, Katsumi</creatorcontrib><creatorcontrib>Yamamoto, Tetsuya</creatorcontrib><title>Embolic Material Migration as the Predominant Contributing Factor to Prognostic Deterioration Following Combined Tumor Resection and Preoperative Embolization</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Introduction Preoperative embolization can potentially facilitate surgical resection of challenging tumors in the intracranial and facial regions; however, its clinical efficacy remains controversial, mainly due to potential morbidity risks. We explored negative factors of the combined treatment of preoperative embolization and tumor resection that affect neurological prognosis. Method This retrospective study used clinical data from 132 consecutive tumors that underwent combined treatment at multiple facilities between January 2016 and May 2021. Basic patient information, tumor characteristics, and treatment details were assessed to identify predictors of deterioration as measured using the modified Rankin scale (mRS) score at three months post-treatment. Results Among the 126 eligible combined treatments, a deterioration in the postoperative mRS score was observed in 19/126 (15.1%). Complications related to embolization and tumor resection occurred in 8/126 (6.3%) and 19/125 (15.2%) of procedures, respectively. Multivariate analyses indicated significant associations between migration of embolic material (adjusted odds ratio 13.80; 95% confidence interval 1.25-152.52; p=0.03), elevated intraoperative blood loss (p=0.04), and deterioration of postoperative mRS score. Embolic material migration was identified as the primary prognostic factor for the deterioration of score. An analysis of 192 procedures, excluding those that exclusively used coils, identified embolization targeting the accessory meningeal artery (p=0.046) and the third segment of the internal maxillary artery (p=0.03) as a risk factor for embolic material migration. Conclusions Embolic material migration is the predominant factor associated with declining neurological outcome that persists into the chronic phase after combined treatment. Given that preoperative embolization is a supplementary treatment option, a thorough understanding of vascular anatomy and striving safe procedure are critical.</description><subject>Asymptomatic</subject><subject>Clinical outcomes</subject><subject>Embolization</subject><subject>Hemorrhage</subject><subject>Lymphoma</subject><subject>Medical prognosis</subject><subject>Migration</subject><subject>Neurological disorders</subject><subject>Neurosurgery</subject><subject>Thromboembolism</subject><subject>Tumors</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkcFu1DAQhi0EolXpjTOyxIUDW-w4jpMTQksXkFqB0N4tx5lsXSWexXZawcPwrDibpSqcbMnffDPjn5CXnF0oJZt3dgowxQupBJdPyGnBq3pV87p8-uh-Qs5jvGWMcaYKpthzciLqqmGlKk_J78uxxcFZem0SBGcGeu12wSSHnppI0w3QbwE6HJ03PtE1-hRcOyXnd3RjbMJAE2YEdx5jyp6PMHvwqNjgMOD9DK9xbJ2Hjm6nMRd9hwh26eK7uQXuYa65A7pM9OsgeEGe9WaIcH48z8h2c7ldf15dff30Zf3hamUFY2llJEioemFkaWxblX0pTassN9BA09dd2SkhheoLU9mGc1FbUXXMiq6XrSkqcUbeL9r91I7QWchbmkHvgxtN-KnROP3vi3c3eod3mnNW5Y8V2fDmaAj4Y4KY9OiihWEwHnCKWrCyUbySUmb09X_oLU7B5_UOVJ2pQmXq7ULZgDEG6B-m4UzP2esle33IPuOvHm_wAP9NWvwBoUKwrA</recordid><startdate>20240331</startdate><enddate>20240331</enddate><creator>Suzuki, Ryosuke</creator><creator>Akimoto, Taisuke</creator><creator>Miyake, Shigeta</creator><creator>Iida, Yu</creator><creator>Shimohigoshi, Wataru</creator><creator>Nakai, Yasunobu</creator><creator>Shimizu, Nobuyuki</creator><creator>Sakata, Katsumi</creator><creator>Yamamoto, Tetsuya</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240331</creationdate><title>Embolic Material Migration as the Predominant Contributing Factor to Prognostic Deterioration Following Combined Tumor Resection and Preoperative Embolization</title><author>Suzuki, Ryosuke ; Akimoto, Taisuke ; Miyake, Shigeta ; Iida, Yu ; Shimohigoshi, Wataru ; Nakai, Yasunobu ; Shimizu, Nobuyuki ; Sakata, Katsumi ; Yamamoto, Tetsuya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-a5e5e6f3a54acb64f45ab7c1ae9e9f8d4d73537f2a6c91138c36d0c3df5ba263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Asymptomatic</topic><topic>Clinical outcomes</topic><topic>Embolization</topic><topic>Hemorrhage</topic><topic>Lymphoma</topic><topic>Medical prognosis</topic><topic>Migration</topic><topic>Neurological disorders</topic><topic>Neurosurgery</topic><topic>Thromboembolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suzuki, Ryosuke</creatorcontrib><creatorcontrib>Akimoto, Taisuke</creatorcontrib><creatorcontrib>Miyake, Shigeta</creatorcontrib><creatorcontrib>Iida, Yu</creatorcontrib><creatorcontrib>Shimohigoshi, Wataru</creatorcontrib><creatorcontrib>Nakai, Yasunobu</creatorcontrib><creatorcontrib>Shimizu, Nobuyuki</creatorcontrib><creatorcontrib>Sakata, Katsumi</creatorcontrib><creatorcontrib>Yamamoto, Tetsuya</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suzuki, Ryosuke</au><au>Akimoto, Taisuke</au><au>Miyake, Shigeta</au><au>Iida, Yu</au><au>Shimohigoshi, Wataru</au><au>Nakai, Yasunobu</au><au>Shimizu, Nobuyuki</au><au>Sakata, Katsumi</au><au>Yamamoto, Tetsuya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Embolic Material Migration as the Predominant Contributing Factor to Prognostic Deterioration Following Combined Tumor Resection and Preoperative Embolization</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2024-03-31</date><risdate>2024</risdate><volume>16</volume><issue>3</issue><spage>e57315</spage><epage>e57315</epage><pages>e57315-e57315</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Introduction Preoperative embolization can potentially facilitate surgical resection of challenging tumors in the intracranial and facial regions; however, its clinical efficacy remains controversial, mainly due to potential morbidity risks. We explored negative factors of the combined treatment of preoperative embolization and tumor resection that affect neurological prognosis. Method This retrospective study used clinical data from 132 consecutive tumors that underwent combined treatment at multiple facilities between January 2016 and May 2021. Basic patient information, tumor characteristics, and treatment details were assessed to identify predictors of deterioration as measured using the modified Rankin scale (mRS) score at three months post-treatment. Results Among the 126 eligible combined treatments, a deterioration in the postoperative mRS score was observed in 19/126 (15.1%). Complications related to embolization and tumor resection occurred in 8/126 (6.3%) and 19/125 (15.2%) of procedures, respectively. Multivariate analyses indicated significant associations between migration of embolic material (adjusted odds ratio 13.80; 95% confidence interval 1.25-152.52; p=0.03), elevated intraoperative blood loss (p=0.04), and deterioration of postoperative mRS score. Embolic material migration was identified as the primary prognostic factor for the deterioration of score. An analysis of 192 procedures, excluding those that exclusively used coils, identified embolization targeting the accessory meningeal artery (p=0.046) and the third segment of the internal maxillary artery (p=0.03) as a risk factor for embolic material migration. Conclusions Embolic material migration is the predominant factor associated with declining neurological outcome that persists into the chronic phase after combined treatment. Given that preoperative embolization is a supplementary treatment option, a thorough understanding of vascular anatomy and striving safe procedure are critical.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>38690474</pmid><doi>10.7759/cureus.57315</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2024-03, Vol.16 (3), p.e57315-e57315
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11060013
source PubMed Central Open Access; PubMed Central
subjects Asymptomatic
Clinical outcomes
Embolization
Hemorrhage
Lymphoma
Medical prognosis
Migration
Neurological disorders
Neurosurgery
Thromboembolism
Tumors
title Embolic Material Migration as the Predominant Contributing Factor to Prognostic Deterioration Following Combined Tumor Resection and Preoperative Embolization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T15%3A36%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Embolic%20Material%20Migration%20as%20the%20Predominant%20Contributing%20Factor%20to%20Prognostic%20Deterioration%20Following%20Combined%20Tumor%20Resection%20and%20Preoperative%20Embolization&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Suzuki,%20Ryosuke&rft.date=2024-03-31&rft.volume=16&rft.issue=3&rft.spage=e57315&rft.epage=e57315&rft.pages=e57315-e57315&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.57315&rft_dat=%3Cproquest_pubme%3E3049816527%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3049816527&rft_id=info:pmid/38690474&rfr_iscdi=true